DOK5 and obesity due to melanocortin 4 receptor deficiency: Because of its involvement in insulin signaling and immune responses which are the key modulating pathways in type 2 diabetes and obesity, DOK5 seems to be a convincing positional and functional candidate for type 2 diabetes and obesity.